Left Atrial Thrombosis
4
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Dabigatranetexilate
Research Leaders
5 sponsors active, led by Boehringer Ingelheim
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Detecting Cardiac Thrombi in Acute Ischemic Stroke on Cardiac CT Versus Transoesophageal Echocardiography
The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.
Uses of CMR in Detection of Left Atrial Thrombus
Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon
Research Network
Common Treatments
- Dabigatranetexilate1
- Cardiac Computed Tomography1
- Phenprocoumon1
- Repeated Cardiac Computed Tomography1
- Transesophageal Echo1
Active Sponsors
- Boehringer Ingelheim1
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
- Assiut University1
- University of Ulm1
- Rambam Health Care Campus1
Top Investigators
assiut medical school
University Hospital Ulm, Department of Internal Medicine II
Amsterdam UMC
Related Conditions
- Atrial Fibrillation2
- Thrombosis Cardiac1
- Ischemic Stroke1
- Left Atrial Appendage Thrombosis1
- Cardioembolic Stroke1